Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 430.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.651%)
Open: 440.00
High: 445.00
Low: 440.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

29 Aug 2006 07:01

Tristel PLC29 August 2006 For release29 August 2006 Tristel Plc Technology Acquisition Agreement with IVC Limited, New Zealand Tristel plc ("Tristel"), the chlorine dioxide specialist that supplies infectionand contamination control products to healthcare and institutionalestablishments and the pharmaceutical and food processing industries, announcesthat it has entered into a technology acquisition agreement with IVC Limited, ("IVC"). IVC is Tristel's New Zealand distributor and its principal shareholderis Mark Fraundorfer, an internationally renowned Urologist. Under the terms of the agreement IVC transfers to Tristel the design and patentrights to two inventions which it has created to work specifically withTristel's chlorine dioxide chemistry. The inventions are a sterilizing traysystem which enables single use decontamination of endoscopic equipment and ahygiene work station which enables Tristel's highly effective sporicidalchemistry to be easily applied to floors and walls in high risk wards anddepartments of hospitals. IVC has funded the design and development process to date and transfers theintellectual property created in return for unspecified future royalties. Commenting upon the agreement, Paul Swinney, Chief Executive of Tristel, said: "Outside of the most advanced healthcare markets, where endoscopes are mainlyprocessed in sophisticated and costly automated machines, the majority ofendoscopes are disinfected in basic trays and sinks. These can only holddisinfectant liquids that have to be used repeatedly for many instruments over aperiod of many hours or even days. "The Tristel tray system, combined with Tristel's novel burstable sachet,Tristel Fusion, enables the disinfectant to be used once and to be dedicated toone instrument only. "This achieves one of the key features of the most sophisticated endoscopereprocessing machines at a fraction of their cost, and will help Tristelpenetrate many overseas markets with its chlorine dioxide disinfectants." Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance Director Tel 020 7493 3716Tel: 01638 721 500 Mob: 07980 541 893http://www.tristel.com paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Apr 20212:06 pmRNSSecond Price Monitoring Extn
26th Apr 20212:00 pmRNSPrice Monitoring Extension
26th Apr 202111:05 amRNSSecond Price Monitoring Extn
26th Apr 202111:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSTrading Update
21st Apr 20213:00 pmRNSIssue of Equity
19th Apr 20211:00 pmRNSIssue of Equity
6th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
26th Mar 202110:40 amRNSIssue of Equity
4th Mar 20217:00 amRNSDirector/PDMR Shareholding
1st Mar 20215:00 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Feb 20217:00 amRNSHalf-year Report
18th Feb 202111:15 amRNSNotice of investor presentation
15th Feb 202111:00 amRNSIssue of Equity
29th Jan 20217:00 amRNSIssue of Equity
14th Jan 20212:00 pmRNSExercise of Options
24th Dec 20207:00 amRNSDirector Appointment
15th Dec 202011:39 amRNSResult of AGM
15th Dec 20207:00 amRNSAGM Statement and notice of results
2nd Dec 20202:00 pmRNSUpdate to Executive Performance Share Plan 2021
2nd Dec 202010:30 amRNSTristel wins AIM Growth Business of the Year Award
9th Nov 20209:49 amRNSExercise of Options
2nd Nov 202010:30 amRNSQ&A update following preliminary results
27th Oct 20204:50 pmRNSIssue of Equity
19th Oct 20203:15 pmRNSDividend Timetable
19th Oct 20207:00 amRNSFinal Results
6th Oct 20207:00 amRNSNotice of Results
5th Oct 20204:41 pmRNSIssue of Equity
2nd Oct 20209:11 amRNSIssue of Equity
7th Sep 20201:16 pmRNSIssue of Equity
21st Aug 20207:00 amRNSTristel’s Duo for Ultrasound approved in India
7th Aug 202010:46 amRNSIssue of Equity
6th Aug 202010:30 amRNSUpdate from Virtual Shareholder Open Day
22nd Jul 20204:43 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSTrading update
23rd Jun 20207:00 amRNSNotice of Trading update, Results & presentation
8th Jun 202010:40 amRNSIssue of Equity
22nd May 20209:47 amRNSIssue of Equity
28th Apr 20203:40 pmRNSIssue of Equity
27th Apr 20207:00 amRNSDirector Appointment
14th Apr 202010:02 amRNSIssue of Equity
7th Apr 202010:38 amRNSIssue of Equity
31st Mar 20208:00 amRNSHolding(s) in Company
25th Mar 202012:38 pmRNSHolding(s) in Company
23rd Mar 20209:05 amRNSSecond Price Monitoring Extn
23rd Mar 20209:00 amRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSLicense & Product Supply Agreement with Byotrol

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.